Schafer Cullen Capital Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-4,439
Closed -$218K – 231
2018
Q2
$218K Sell
4,439
-59,185
-93% -$3.36M ﹤0.01% 230
2018
Q1
$3.8M Buy
63,624
+96
+0.2% +$6.4K 0.05% 128
2017
Q4
$5M Sell
63,528
-2,011
-3% -$162K 0.06% 125
2017
Q3
$5.5M Sell
65,539
-2,218
-3% -$157K 0.07% 112
2017
Q2
$4.43M Sell
67,757
-3,168
-4% -$215K 0.06% 114
2017
Q1
$5.15M Sell
70,925
-2,028
-3% -$133K 0.07% 116
2016
Q4
$4.28M Buy
+72,953
New +$3.85M 0.06% 127

Other funds holding ADNT

Schafer Cullen Capital Management's ADNT Position: Q3 2018 in Review

Schafer Cullen Capital Management sold out of Adient (ADNT) in Q3 2018, closing a stake of 4,439 shares — an estimated $218K sold.

Schafer Cullen Capital Management first reported a position in ADNT in Q4 2016 and held it in 7 quarters. The position peaked at $5.5M in Q3 2017. 401 funds tracked by Wall St. Rank hold ADNT as of Q3 2018.

  • Schafer Cullen Capital Management reported no remaining Adient position as of Q3 2018 after selling out during the quarter.
  • Schafer Cullen Capital Management sold 4,439 Adient shares in Q3 2018, an estimated $218K.
  • Schafer Cullen Capital Management first reported a position in Adient in Q4 2016 and held it in 7 quarters.
  • Schafer Cullen Capital Management's Adient position peaked at $5.5M in Q3 2017.
  • 401 funds tracked by Wall St. Rank held Adient as of Q3 2018.

Based on Schafer Cullen Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.